Treatment of Melasma With Jessner's Solution Vs. Trichloroacetic Acid - Full Text View

Treatment of Melasma With Jessner's Solution Vs. Trichloroacetic Acid

This study is currently recruiting participants.
Verified by Emory University, September 2005

Sponsored by:	Emory University
Information provided by:	Emory University
ClinicalTrials.gov Identifier:	NCT00166192

Purpose

Melasma is an acquired discoloration of the skin characterized by brown patches. Chemical peels using agents such as Jessner's solution and trichloroacetic acid (TCA) are commonly used to treat melasma. A chemical peel involves applying the peeling agent to the skin for a short period. The skin will peel similar to a sunburn, and moisturizers are applied to the skin. Although both agents are well-accepted, there have been no good comparisons of the two agents. The purpose of this study is determine if there is a difference in the effectiveness of these two agents.

Condition	Intervention	Phase
Melasma	Procedure: Jessner's solution chemical peel Procedure: Trichloroacetic acid chemical peel	Phase IV

ChemIDplus related topics:

Trichloroacetic acid

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Official Title:	Treatment of Melasma With Jessner's Solution Vs. Trichloroacetic Acid: A Comparison of Clinical Efficacy

Further study details as provided by Emory University:

Primary Outcome Measures:

Clinical efficacy by clinician's evaluation

Secondary Outcome Measures:

Efficacy by subject's evaluation

Estimated Enrollment:	113
Study Start Date:	January 2004

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adults > 18 years old
Clinical diagnosis of melasma
Mental capacity to give informed consent

Exclusion Criteria:

Pregnancy
H/o allergy to Jessner's solution, tricholoracetetic acid, tretinoin, or hydroquinone
Active dermatitis
Presence of cutaneous infection

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00166192

Contacts


Contact: Carl Washington, MD	404-778-3354	cwashin@emory.edu

Locations


United States, Georgia
	Emory University Dermatology Clinic	Recruiting
	Atlanta, Georgia, United States, 30322
	Contact: Lynae Stewart 404-778-4827
	Principal Investigator: Carl Washington, MD
	Sub-Investigator: Tracy Bialy, MD
	Sub-Investigator: Tanda Lane, MD

Sponsors and Collaborators

Emory University

Investigators


Principal Investigator:	Carl Washington, MD	Emory University Department of Dermatology

More Information

Study ID Numbers:	904-2003
First Received:	September 13, 2005
Last Updated:	September 13, 2005
ClinicalTrials.gov Identifier:	NCT00166192
Health Authority:	United States: Food and Drug Administration

Keywords provided by Emory University:

Melasma

Jessner's solution

Trichloroacetic acid (TCA)

Study placed in the following topic categories:

Hyperpigmentation

Skin Diseases

Melanosis

Ethanol

Additional relevant MeSH terms:

Anti-Infective Agents

Anti-Infective Agents, Local

Therapeutic Uses

Pigmentation Disorders

Physiological Effects of Drugs

Central Nervous System Depressants

Central Nervous System Agents

Pharmacologic Actions

ClinicalTrials.gov processed this record on October 07, 2008